Founded
Address
ARCH Venture Partners
1700 Owens Street
Suite 535
San Francisco, CA 94158
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 30599
Corporate information
Official name
ARCH Venture Partners LP
Registration country
Official identities
US CIK 0001666306
Company type
Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startupFunds managed
Fund | Type | Vintage | Currency | Committed capital | IRR | x |
---|---|---|---|---|---|---|
ARCH Venture Fund IX LP | Venture | 2016 | USD | 408,400,000 | ||
ARCH Venture Fund VIII Overage LP | Venture | 2015 | USD | 150,000,000 | ||
ARCH Venture Fund VIII LP | Venture | 2014 | USD | 400,532,000 | ||
ARCH Venture Fund VII LP | Venture | 2007 | 40.69 % | 3.99 x | ||
ARCH Venture Fund VI LP | Venture | 2003 | 3.49 % | 1.09 x | ||
ARCH Venture Fund V LP | Venture | 2000 | ||||
ARCH Venture Partners IV | Venture | 1999 | USD | 175,000,000 | ||
ARCH Venture Partners III | Venture | 1997 | USD | 107,000,000 | ||
ARCH Venture Partners II | Venture | 1993 |
Funding rounds
Investor | Profile | Country | |
---|---|---|---|
![]() |
Chevron Technology Ventures LLC (CTV) | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron |
Top investment portfolio themes
accelerator (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 136Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
![]() |
Acylin Therapeutics Inc | N/A | ||||
![]() |
Adolor Corp | N/A | ||||
![]() |
Agios Pharmaceuticals Inc | N/A | ||||
![]() |
Ahura Scientific Inc | N/A | ||||
![]() |
ALIS Corp | N/A | ||||
![]() |
Alnylam Pharmaceuticals Inc | N/A | ||||
![]() |
Apoptos Inc | N/A | ||||
![]() |
Apropos Technology Inc | N/A | ||||
![]() |
Artificial Muscle Inc | N/A | ||||
![]() |
Aveso Inc | N/A | ||||
![]() |
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Series D | |||
![]() |
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Venture | |||
![]() |
Caliper Life Sciences Inc | N/A | ||||
![]() |
Callisto Software Inc | N/A | ||||
![]() |
Celebrate Express Inc | N/A | ||||
![]() |
Celula Inc | N/A | ||||
![]() |
CEPTYR Inc | N/A | ||||
![]() |
Chiasma Corp | Series C | ||||
![]() |
Ciespace Corp | Series A | ||||
![]() |
Classmates Media Corp | N/A | ||||
![]() |
ClassMates Online Inc | Provider of an on-line computer database. | N/A | |||
![]() |
CoolEdge Lighting Inc | N/A | ||||
![]() |
Eichrom Technologies Inc | N/A | ||||
![]() |
Ekos Corp | N/A | ||||
![]() |
Elixir Pharmaceuticals Inc | N/A |
Pagination
Team
Employee | Position | |||
---|---|---|---|---|
Clinton Bybee (founder) | Managing Director (past)
|
[email protected] | ||
Keith Crandell (founder) | [email protected] | |||
Robert Nelsen (founder) | [email protected] | |||
Kristina Burow | [email protected] | |||
David Cruikshank | Associate (past)
|
[email protected] | ||
Steven Gillis | [email protected] | |||
Edgar Hotard | [email protected] | |||
Ajit Medhekar | [email protected] | |||
Paul Thurk | [email protected] |
Former team members
Employee | Company | Position | ||
---|---|---|---|---|
![]() |
Scott Minick | Bind Biosciences Inc | ||
![]() |
Scott Minick | Delin Ventures |